Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (551-560 of 1,253) with videos related to

Pageof 126
Sort By:
European Journal of Heart Failure|September 29, 2005
Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM ProgramGary F Mitchell, J Malcolm O Arnold, Mark E Dunlap, et al.
Resuscitation Plus|February 2, 2024
Factors influencing support for the implementation of community-based out-of-hospital cardiac arrest interventions in high- and low-performing countiesNatalie Ezem, Allison A Lewinski, Julie Miller, et al.
JACC. Advances|March 21, 2025
Apixaban Dose in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention: Insights From AUGUSTUSMarat Fudim, Renato D Lopes, Daniel M Wojdyla, et al.
American Heart Journal|August 23, 2006
Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasmaMark P Donahue, Keith Rose, Denis Hochstrasser, et al.
Circulation|November 16, 1999
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevationD R Holmes, P B Berger, J S Hochman, et al.
Journal of Thrombosis and Thrombolysis|April 26, 2003
The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIbMichael S Lee, Andreas U Wali, Venu Menon, et al.
American Heart Journal|February 26, 2008
Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issuesE Marc Jolicoeur, E Magnus Ohman, Robert Temple, et al.
Journal of the American College of Cardiology|July 6, 2004
Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic SubstudyTaha Taher, Yuling Fu, Galen S Wagner, et al.
European Heart Journal|February 5, 2010
Towards a new order in cardiovascular medicine: re-engineering through global collaborationRobert M Califf, Paul W Armstrong, Christopher B Granger, et al.
Circulation|March 5, 2014
Response to letter regarding article, "Emergency department bypass for ST-segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline Program"Akshay Bagai, James G Jollis, Harold L Dauerman, et al.
Pageof 126

Showing results (551-560 of 1,253) with videos related to

Sort By:
Pageof 126
European Journal of Heart Failure|September 29, 2005
Pulsatile hemodynamic effects of candesartan in patients with chronic heart failure: the CHARM ProgramGary F Mitchell, J Malcolm O Arnold, Mark E Dunlap, et al.
Resuscitation Plus|February 2, 2024
Factors influencing support for the implementation of community-based out-of-hospital cardiac arrest interventions in high- and low-performing countiesNatalie Ezem, Allison A Lewinski, Julie Miller, et al.
JACC. Advances|March 21, 2025
Apixaban Dose in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention: Insights From AUGUSTUSMarat Fudim, Renato D Lopes, Daniel M Wojdyla, et al.
American Heart Journal|August 23, 2006
Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasmaMark P Donahue, Keith Rose, Denis Hochstrasser, et al.
Circulation|November 16, 1999
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevationD R Holmes, P B Berger, J S Hochman, et al.
Journal of Thrombosis and Thrombolysis|April 26, 2003
The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIbMichael S Lee, Andreas U Wali, Venu Menon, et al.
American Heart Journal|February 26, 2008
Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issuesE Marc Jolicoeur, E Magnus Ohman, Robert Temple, et al.
Journal of the American College of Cardiology|July 6, 2004
Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic SubstudyTaha Taher, Yuling Fu, Galen S Wagner, et al.
European Heart Journal|February 5, 2010
Towards a new order in cardiovascular medicine: re-engineering through global collaborationRobert M Califf, Paul W Armstrong, Christopher B Granger, et al.
Circulation|March 5, 2014
Response to letter regarding article, "Emergency department bypass for ST-segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline Program"Akshay Bagai, James G Jollis, Harold L Dauerman, et al.
Pageof 126